Remala Abadi Tbk PT
IDX:DATA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
740
6 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Remala Abadi Tbk PT
|
Revenue
|
413.6B
IDR
|
|
Cost of Revenue
|
-85.9B
IDR
|
|
Gross Profit
|
327.7B
IDR
|
|
Operating Expenses
|
-158.1B
IDR
|
|
Operating Income
|
169.6B
IDR
|
|
Other Expenses
|
-60.5B
IDR
|
|
Net Income
|
109.1B
IDR
|
Income Statement
Remala Abadi Tbk PT
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
2 555
|
2 566
|
0
|
0
|
|
| Revenue |
348 192
N/A
|
375 834
+8%
|
424 618
+13%
|
413 613
-3%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(84 612)
|
(91 327)
|
(100 431)
|
(85 924)
|
|
| Gross Profit |
263 580
N/A
|
284 507
+8%
|
324 188
+14%
|
327 688
+1%
|
|
| Operating Income | |||||
| Operating Expenses |
(116 169)
|
(133 925)
|
(153 250)
|
(158 092)
|
|
| Selling, General & Administrative |
(107 051)
|
(123 794)
|
(143 992)
|
(147 081)
|
|
| Depreciation & Amortization |
(10 509)
|
(11 663)
|
(10 649)
|
(10 603)
|
|
| Other Operating Expenses |
1 391
|
1 532
|
1 390
|
(408)
|
|
| Operating Income |
147 411
N/A
|
150 582
+2%
|
170 937
+14%
|
169 597
-1%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
(1 875)
|
(1 669)
|
(2 475)
|
(7 249)
|
|
| Non-Reccuring Items |
142
|
0
|
(5 717)
|
(5 717)
|
|
| Total Other Income |
(455)
|
(36)
|
(11 058)
|
(10 656)
|
|
| Pre-Tax Income |
145 223
N/A
|
148 878
+3%
|
151 687
+2%
|
145 976
-4%
|
|
| Net Income | |||||
| Tax Provision |
(33 377)
|
(34 682)
|
(35 249)
|
(33 455)
|
|
| Income from Continuing Operations |
111 847
|
114 195
|
116 438
|
112 521
|
|
| Income to Minority Interest |
(2 853)
|
(3 200)
|
(2 311)
|
(3 463)
|
|
| Net Income (Common) |
96 590
N/A
|
98 591
+2%
|
101 724
+3%
|
109 058
+7%
|
|
| EPS (Diluted) |
75.52
N/A
|
71.7
-5%
|
73.98
+3%
|
79.3
+7%
|
|